Drug Shortage Report for MYLAN-VERAPAMIL SR
Report ID | 200642 |
Drug Identification Number | 02210347 |
Brand name | MYLAN-VERAPAMIL SR |
Common or Proper name | VERAPAMIL SR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-10-03 |
Actual start date | 2023-10-05 |
Estimated end date | 2024-02-13 |
Actual end date | 2024-02-09 |
Shortage status | Resolved |
Updated date | 2024-02-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-08-01 | English | Compare |